VASH2 is reportedly expressed in many common tumors, like hepatocellular carcinoma, serous ovarian adenocarcinoma and gastric cancer, and participates in the program of tumor metabolism, such as angiogenesis [8], [10], [44]. This evidence concerns the gene VASH2 and ovarian serous adenocarcinoma.